Philipp Stoffers

Philipp Stoffers

Auto-generated profile, based on publicly available information

Philipp Stoffers

Digital Health Center, Hasso Plattner Institute, University of Potsdam, Potsdam, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CGChristiana Graf
Christiana Graf
TWTania Welzel
Tania Welzel
DBDimitra Bogdanou
Dimitra Bogdanou
JVJohannes Vermehren
Johannes Vermehren
ABAnita Beckel
Anita Beckel
UMUlrike Mihm
Ulrike Mihm
Background: Chronic hepatitis C virus (HCV) infections are causally linked with metabolic comorbidities such as insulin resistance, hepatic steatosis, and dyslipidemia. However, the clinical impact of HCV eradication achieved by direct-acting antivirals (DAAs) on glucose and lipid homeostasis is still controversial. The study aimed to prospectively investigate whether antiviral therapy of HCV with DAAs alters glucose and lipid parameters. Methods: 50 patients with chronic HCV who were treated with DAAs were screened, and 49 were enrolled in the study. Biochemical and virological data, as well as noninvasive liver fibrosis parameters, were prospectively collected at baseline, at the end of treatment (EOT) and 12 and 24 weeks post-treatment. Results: 45 of 46 patients achieved sustained virologic response (SVR). The prevalence of insulin resistance (HOMA-IR) after HCV clearance was significantly lower, compared to baseline (5.3 ± 6.1 to 2.5 ± 1.9, p < 0.001), which is primarily attributable to a significant decrease of fasting insulin levels (18.9 ± 17.3 to 11.7 ± 8.7; p = 0.002). In contrast to that, HCV eradication resulted in a significant increase in cholesterol levels (total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein (HDL-C) levels) and Controlled Attenuated Score (CAP), although BMI did not significantly change over time (p = 0.95). Moreover, HOMA-IR correlated significantly with noninvasive liver fibrosis measurements at baseline und during follow-up (TE: r = 0.45; p = 0.003, pSWE: r = 0.35; p = 0.02, APRI: r = 0.44; p = 0.003, FIB-4: r = 0.41; p < 0.001). Conclusion: Viral eradication following DAA therapy may have beneficial effects on glucose homeostasis, whereas lipid profile seems to be worsened.

25 August 2022 in Liver International
Verified
Journal Article
Open access
MMMartin S. McCoy
Martin S. McCoy
JMJan Mengers
Jan Mengers
WGWenyi Gu
Wenyi Gu
ADAndreas Drolz
Andreas Drolz
PFPhilip Georg Ferstl
Philip Georg Ferstl
JTJonel Trebicka
Jonel Trebicka
Background & Aims: In ACLF patients, an adequate risk stratification is essential, especially for liver transplant allocation, since ACLF is associated with high short‐term mortality. The CLIF‐C ACLF score is the best prognostic model to predict outcome in ACLF patients. While lung failure is generally regarded as signum malum in ICU care, this study aims to evaluate and quantify the role of pulmonary impairment on outcome in ACLF patients. Methods: In this retrospective study, 498 patients with liver cirrhosis and admission to IMC/ICU were included. ACLF was defined according to EASL‐CLIF criteria. Pulmonary impairment was classified into three groups: unimpaired ventilation, need for mechanical ventilation and defined pulmonary failure. These factors were analysed in different cohorts, including a propensity score‐matched ACLF cohort. Results: Mechanical ventilation and pulmonary failure were identified as independent risk factors for increased short‐term mortality. In matched ACLF patients, the presence of pulmonary failure showed the highest 28‐day mortality (83.7%), whereas mortality rates in ACLF with mechanical ventilation (67.3%) and ACLF without pulmonary impairment (38.8%) were considerably lower ( p < .001). Especially in patients with pulmonary impairment, the CLIF‐C ACLF score showed poor predictive accuracy. Adjusting the CLIF‐C ACLF score for the grade of pulmonary impairment improved the prediction significantly. Conclusions: This study highlights that not only pulmonary failure but also mechanical ventilation is associated with worse prognosis in ACLF patients. The grade of pulmonary impairment should be considered in the risk assessment in ACLF patients. The new score may be useful in the selection of patients for liver transplantation.

17 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PSPhilipp Stoffers
Philipp Stoffers
SGSabrina Guckenbiehl
Sabrina Guckenbiehl
MWMartin Walter Welker
Martin Walter Welker
SZStefan Zeuzem
Stefan Zeuzem
CLChristian Markus Lange
Christian Markus Lange
CWChristoph Welsch
Christoph Welsch
Background: The transition from compensated to decompensated liver cirrhosis is a hallmark of disease progression, however, reliable predictors to assess the risk of decompensation in individual patients from routine diagnostics are lacking. Here, we characterize serum levels of cell death-associated markers and routine biochemistry from patients with chronic liver disease with and without decompensation. Methods: A post-hoc analysis was based on prospectively collected clinical data from 160 patients with chronic liver disease, stably compensated or decompensated at baseline or during follow-up, over a median period of 721 days. Serum levels of damage-associated molecular patterns (DAMPs) and routine biochemistry are quantified at baseline (for all patients) and during follow-up (for patients with acute decompensation). The panel of DAMPs assessed in this study comprises high-mobility group-box protein 1 (HMGB1), cytochrome C (cyt C), soluble Fas-ligand (sFasL), interleukin 6 (IL-6), soluble cytokeratin-18 (CK18-M65) and its caspase‐cleaved fragment CK18-M30. Results: In this cohort study, 80 patients (50%) were diagnosed with alcoholic liver cirrhosis, 60 patients (37.5%) with hepatitis C virus- and 20 patients (13.5%) with hepatitis B virus-related liver cirrhosis. At baseline, 17 patients (10.6%) showed decompensated liver disease and another 28 patients (17.5%) developed acute decompensation during follow-up (within 24 months). One hundred fifteen patients showed stable liver disease (71.9%). We found DAMPs significantly elevated in patients with decompensated liver disease versus compensated liver disease. Patients with acute decompensation during follow-up showed higher baseline levels of IL-6, sFasL, CK18-M65 and–M30 (P<0.01) compared to patients with stably compensated liver disease. In multivariate analyses, we found an independent association of baseline serum levels of sFasL (P = 0.02; OR = 2.67) and gamma-glutamyl transferase (GGT) (P<0.001; OR = 2.1) with acute decompensation. Accuracy of the marker combination for predicting acute decompensation was high (AUC = 0.79). Elevated aminotransferase levels did not correlate with decompensated liver disease and acute decompensation. Conclusions: DAMPs are elevated in patients with decompensated liver disease and patients developing acute decompensation. The prognostic value of a marker combination with soluble Fas-ligand and GGT in patients with liver cirrhosis should be further evaluated.

5 August 2026 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
NRNazanin Rostamian
Nazanin Rostamian
MGMaria Fernanda Lopez Gomez
Maria Fernanda Lopez Gomez
PSPhilipp Stoffers
Philipp Stoffers
MCMichael Cassel
Michael Cassel
Background: For children and adolescents active in organized sports, a relationship between spondylolisthesis and low back pain (LBP) has been postulated. Reported prevalence rates vary widely due to inconsistent definitions, populations, and diagnostic methods. Reliable data are needed to inform preventive strategies and clinical decisions, particularly for adolescents engaged in sports. Purpose: To conduct a systematic review on the prevalence and incidence of radiologically confirmed spondylolisthesis in children and adolescents, considering age, organized sports participation, LBP, and the diagnostic method used. Study Design: Systematic review, Level of evidence, 4. Methods: Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, PubMed, Scopus, and Web of Science databases were searched by 2 independent reviewers up to August 01, 2025. Original studies reporting cross-sectional or longitudinal data on radiologically confirmed spondylolisthesis in those ≤20 years of age were included. Subgroups were defined by participation in organized sports and LBP: general population (GP/GP-LBP) and individuals active in organized sports (AS/AS-LBP). Descriptive statistics (median [interquartile range, IQR]) were used to analyze subgroups. Correlations between age and prevalence were estimated using the Spearman rank correlation. Study quality was assessed with the Joanna Briggs Institute (JBI) Checklist for Studies Reporting Prevalence Data, and bias was evaluated according to the Cochrane Handbook. Results: Out of 1566 records, 21 studies (n = 5623; median age 13.1 years [IQR, 11.2-15 years]) were included. The median JBI score was 78% (7 high-, 11 moderate-, 3 low-quality). The pooled prevalence of spondylolisthesis in childhood and adolescence was 3.4% [IQR, 1.9%-4.9%]. Subgroup analyses showed higher prevalence in AS (median, 4.5% [IQR, 4.2%-5.2%]) and AS-LBP (5.3%) compared with GP (median, 2.3% [IQR, 0.5%-2.7%]) and GP-LBP (median, 3.8% [IQR, 2.3%-5.2%]). A positive correlation with age was observed for the AS group ( P = .61). Incidence was reported in only 1 study. Magnetic resonance imaging-based studies reported higher prevalence estimates than computed tomography- or radiography-based studies in descriptive comparisons. Conclusion: Our study demonstrates that the prevalence of spondylolisthesis increases with age, participation in organized sports, and LBP, indicating a significant number of acquired cases during adolescence. Reported prevalence rates vary depending on the diagnostic method used. Incidence remains insufficiently characterized, underscoring the need for standardized longitudinal research improving evidence on the development of isthmic spondylolisthesis. These findings suggest that repetitive mechanical loading of the pars interarticularis may represent a key underlying mechanism.